Gifon 2 mg (Tablet)
Unit Price: ৳ 5.00 (30's pack: ৳ 150.00)
Medicine Details
| Category | Details |
|---|---|
| Generic | Glimepiride |
| Company | Monicopharma ltd |
| Also available as |
Indications
- Lowering blood glucose in Type II diabetes mellitus
- Adjunct to diet and exercise
- Use in combination with insulin
- Potential for hypoglycemia with combined use of insulin
- Control of hyperglycemia
Pharmacology
- Sulfonylurea antidiabetic agent
- Stimulates insulin release from pancreatic beta cells
- Improves sensitivity of beta cells to glucose stimulus
- Reduces basal hepatic glucose production
- Increases peripheral tissue sensitivity to insulin
- Effect on non-fasting diabetic patients
Dosage
- Determined by desired blood sugar level
- Initial and maintenance doses based on glucose monitoring
- Gradual dose titration
- Dose range in well controlled diabetes
- Timing and distribution of doses
- Secondary dosage adjustment
- Changeover from other oral antidiabetics
Administration
- Required method of ingestion: swallowing with liquid
Interaction
- Drugs potentiating hypoglycemic action
- Drugs attenuating hypoglycemic action
- Effect of concomitant treatment with specific drugs
- Effect of alcohol intake
Contraindications
- Not suitable for insulin dependent diabetes mellitus
- Not suitable for diabetic ketoacidosis or diabetic coma
- Hypersensitivity to Glimepiride or sulfonylureas
- Severe hepatic dysfunction
- Severe impairment of renal function
- Patients on dialysis
Side Effects
- Hypoglycemia
- Temporary visual impairment
- Gastrointestinal effects
- Urticaria
- Fall in blood pressure
Pregnancy & Lactation
- Not to be taken during pregnancy
- Need for changeover to insulin during pregnancy
- Harmful effects through breastfeeding
Precautions & Warnings
- Increased risk of hypoglycemia in initial weeks of treatment
- Necessity for careful monitoring
- Prompt control of hypoglycemia with carbohydrate intake
- Dosage adjustment in case of hypoglycemia risk
Overdose Effects
- Hypoglycemic symptoms
- Treatment for mild hypoglycemic symptoms
- Severe hypoglycemic reactions as medical emergencies
- Immediate hospitalization
- Treatment for hypoglycemic coma
- Necessity for continuous monitoring
Therapeutic Class
- Sulfonylureas
Storage Conditions
- Temperature not to exceed 30°C
- Protection from light
- Keep out of the reach of children